Michael Ryskin
Stock Analyst at B of A Securities
(1.48)
# 3,480
Out of 5,182 analysts
41
Total ratings
52%
Success rate
-2.81%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Maintains: Neutral | $7 → $6 | $3.11 | +92.93% | 3 | Feb 26, 2026 | |
| ZTS Zoetis | Maintains: Neutral | $135 → $140 | $117.94 | +18.70% | 8 | Feb 13, 2026 | |
| SDGR Schrödinger | Upgrades: Buy | $24 | $11.58 | +107.25% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $88.94 | +11.31% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $47.39 | +47.71% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $569.55 | -16.60% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $2.95 | +171.19% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $170.60 | +20.75% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $93.83 | -57.37% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $0.55 | +1,624.76% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $5.41 | +343.62% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $7.90 | +203.80% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.06 | +226.80% | 2 | Nov 10, 2021 |
Recursion Pharmaceuticals
Feb 26, 2026
Maintains: Neutral
Price Target: $7 → $6
Current: $3.11
Upside: +92.93%
Zoetis
Feb 13, 2026
Maintains: Neutral
Price Target: $135 → $140
Current: $117.94
Upside: +18.70%
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $11.58
Upside: +107.25%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $88.94
Upside: +11.31%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $47.39
Upside: +47.71%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $569.55
Upside: -16.60%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.95
Upside: +171.19%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $170.60
Upside: +20.75%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $93.83
Upside: -57.37%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $0.55
Upside: +1,624.76%
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $5.41
Upside: +343.62%
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $7.90
Upside: +203.80%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.06
Upside: +226.80%